<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Causal-Inference | Qingzhou Zhang</title>
    <link>https://zqzneptune.github.io/tags/causal-inference/</link>
      <atom:link href="https://zqzneptune.github.io/tags/causal-inference/index.xml" rel="self" type="application/rss+xml" />
    <description>Causal-Inference</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>©2014-2025 Qingzhou Zhang (CC) BY-NC-SA 4.0. All thoughts and opinions here are my own.</copyright><lastBuildDate>Thu, 04 Feb 2021 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://zqzneptune.github.io/images/icon_huf504e8a2f7c5cf9e43cec507892894a0_49847_512x512_fill_lanczos_center_2.png</url>
      <title>Causal-Inference</title>
      <link>https://zqzneptune.github.io/tags/causal-inference/</link>
    </image>
    
    <item>
      <title>The Blueprint for Causal Biology: CROP-seq Links Gene to Function at Scale</title>
      <link>https://zqzneptune.github.io/post/2021-02-04_cropseqinit/</link>
      <pubDate>Thu, 04 Feb 2021 00:00:00 +0000</pubDate>
      <guid>https://zqzneptune.github.io/post/2021-02-04_cropseqinit/</guid>
      <description>&lt;h2 id=&#34;the-core-finding-in-a-nutshell&#34;&gt;The Core Finding in a Nutshell&lt;/h2&gt;
&lt;p&gt;I&amp;rsquo;ve been thinking a lot about the foundational papers that enable my entire research program, and this 2017 classic from Christoph Bock&amp;rsquo;s lab is undoubtedly one of them. Datlinger et al. present CROP-seq, a method that ingeniously combines pooled CRISPR screening with single-cell RNA sequencing. By engineering a lentiviral vector that makes the guide RNA (gRNA) itself detectable in a standard scRNA-seq workflow, they created a one-pot system to knock out thousands of different genes and read out their full transcriptomic consequences in thousands of individual cells.&lt;/p&gt;
&lt;h2 id=&#34;beyond-live-or-die-the-quest-for-richer-functional-screens&#34;&gt;Beyond &amp;lsquo;Live or Die&amp;rsquo;: The Quest for Richer Functional Screens&lt;/h2&gt;
&lt;p&gt;For years, functional genomics was caught between two paradigms. On one hand, you had pooled CRISPR screens—incredibly powerful and scalable, but limited to crude, binary readouts like cell survival or the expression of a single fluorescent reporter. They could tell you &lt;em&gt;if&lt;/em&gt; a gene was important, but not &lt;em&gt;why&lt;/em&gt;. On the other hand, you had arrayed screens, where you&amp;rsquo;d knock out one gene per well. This allowed for rich readouts like RNA-seq, but it was painfully low-throughput and expensive. The central challenge was clear: how do we get the rich, molecular-level data of arrayed screens at the scale of a pooled screen? How do we move beyond simple correlation to build a causal, predictive understanding of gene function?&lt;/p&gt;
&lt;h2 id=&#34;the-elegant-hack-making-grnas-visible-to-the-sequencer&#34;&gt;The Elegant Hack: Making gRNAs Visible to the Sequencer&lt;/h2&gt;
&lt;p&gt;The technical barrier was that gRNAs are transcribed by RNA Polymerase III and lack the poly-A tails needed for capture by the oligo-dT primers used in most scRNA-seq protocols. The CROP-seq vector is the solution, and it’s a beautiful piece of molecular engineering. The authors placed the entire gRNA expression cassette within the 3&amp;rsquo; Long Terminal Repeat (LTR) of a lentiviral vector. A quirk of lentiviral replication is that this 3&amp;rsquo; LTR is duplicated to the 5&amp;rsquo; end upon integration into the host genome. The result is that the gRNA sequence becomes part of a polyadenylated RNA Polymerase II transcript, making it perfectly visible to the sequencer alongside the cell&amp;rsquo;s own mRNAs. Critically, the original cassette still expresses a functional gRNA to direct Cas9. This allows the core computational step: in a massive pool of sequenced cells, we can now unambiguously assign a specific genetic perturbation (the gRNA) to a specific phenotypic outcome (the single-cell transcriptome).&lt;/p&gt;
&lt;h2 id=&#34;the-barcode-is-the-message&#34;&gt;The Barcode Is the Message&lt;/h2&gt;
&lt;p&gt;For me, the most profound insight of this paper is its design simplicity. While concurrent methods like the initial version of Perturb-seq used a separate transcribed barcode, CROP-seq makes the gRNA sequence &lt;em&gt;itself&lt;/em&gt; the identifier. This is not a minor detail. It means the method is fully compatible with standard, widely available pooled gRNA libraries and cloning protocols. By making the perturbing agent its own detectable barcode, they dramatically lowered the barrier to entry and created a system built for massive scale. This is the kind of thinking that truly democratizes a technology and unlocks its full potential.&lt;/p&gt;
&lt;h2 id=&#34;a-foundational-tool-for-my-predictive-modeling-mission&#34;&gt;A Foundational Tool for My Predictive Modeling Mission&lt;/h2&gt;
&lt;p&gt;This paper, along with the seminal Perturb-seq papers from the Regev and Weissman labs published around the same time, provides the technological bedrock for my entire mission to build predictive models of living tissues. My goal is to move from descriptive snapshots to causal, predictive digital twins. CROP-seq is the engine that produces the exact kind of data I need: high-throughput, high-dimensional measurements of causal relationships between genotype (the knockout) and phenotype (the transcriptome).&lt;/p&gt;
&lt;p&gt;The authors&amp;rsquo; proof-of-concept screen of T-cell receptor signaling in Jurkat cells—a T-ALL cell line—is a direct signpost for my primary research pillar. I can immediately see the path to applying this exact framework to dissect the gene regulatory networks that drive chemoresistance in youth leukemia. By perturbing genes and observing the resulting transcriptomic shifts in the face of chemotherapy, we can build models that predict which pathways a cancer cell will use to evade treatment. This is the blueprint.&lt;/p&gt;
&lt;h2 id=&#34;from-pathways-to-networks-the-next-computational-frontier&#34;&gt;From Pathways to Networks: The Next Computational Frontier&lt;/h2&gt;
&lt;p&gt;This work opens the door, but the journey is just beginning. The analytical approach in the paper largely involves averaging the transcriptomes of all cells that received the same gRNA to create a bulk-like &amp;ldquo;signature.&amp;rdquo; This is powerful, but it discards the rich heterogeneity that is the whole point of single-cell analysis.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;My Next Computational Step:&lt;/strong&gt; Instead of calculating an average perturbation effect, my focus is on modeling the full &lt;em&gt;distribution&lt;/em&gt; of cellular states that arise from a single knockout. Drug resistance is rarely a uniform phenomenon; it emerges from the tails of a distribution. By modeling how a perturbation reshapes this distribution, we can identify the rare, emergent cell states that lead to treatment failure. This data is the ideal fuel for training the interpretable Gene Regulatory Network (GRN) models that are central to my lab&amp;rsquo;s vision, allowing us to predict perturbation effects &lt;em&gt;in silico&lt;/em&gt;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Key Experiment for the Field:&lt;/strong&gt; The next essential move is to take this technology from sterile cell culture plates into more complex, physiologically relevant systems. A pivotal experiment would be to perform a CROP-seq screen in a patient-derived xenograft (PDX) model of B-ALL during chemotherapy treatment. This would allow us to screen for drivers of resistance not in isolation, but within the context of a living tumor microenvironment, revealing the causal gene networks that matter in a patient.&lt;/p&gt;
&lt;h2 id=&#34;scrutinizing-the-signal-limitations-and-lookouts&#34;&gt;Scrutinizing the Signal: Limitations and Lookouts&lt;/h2&gt;
&lt;p&gt;Of course, no method is without its limitations. The primary challenge with this approach is statistical power. The transcriptomic effect of a single gene knockout can be subtle, especially for genes in redundant pathways. This means a large number of cells must be sequenced for each gRNA to confidently detect a signal, which has cost implications. Furthermore, the capture efficiency of the gRNA transcript isn&amp;rsquo;t perfect, leading to some cells where we get a transcriptome but can&amp;rsquo;t identify the perturbation. Finally, the reliance on lentivirus is a key constraint; it works beautifully in immortalized cell lines but can be challenging to implement in primary cells, particularly non-dividing ones like mature neurons, which is a consideration for my long-term neurodegeneration work. Acknowledging these practical hurdles is the first step in designing the next generation of experiments.&lt;/p&gt;
&lt;hr&gt;
&lt;h3 id=&#34;reference&#34;&gt;Reference&lt;/h3&gt;
&lt;p&gt;Datlinger, Paul, et al. &lt;a href=&#34;https://www.nature.com/articles/nmeth.4177&#34;&gt;&amp;ldquo;Pooled CRISPR screening with single-cell transcriptome readout.&amp;quot;&lt;/a&gt; Nature methods 14.3 (2017): 297-301.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Perturb-Seq: Moving from &#39;What Is&#39; to &#39;What If&#39; in a Single Experiment</title>
      <link>https://zqzneptune.github.io/post/2021-02-03_perturbseqinit/</link>
      <pubDate>Wed, 03 Feb 2021 00:00:00 +0000</pubDate>
      <guid>https://zqzneptune.github.io/post/2021-02-03_perturbseqinit/</guid>
      <description>&lt;h2 id=&#34;the-bottom-line-up-front&#34;&gt;The Bottom Line Up Front&lt;/h2&gt;
&lt;p&gt;I&amp;rsquo;ve just revisited the foundational 2016 &lt;em&gt;Cell&lt;/em&gt; paper from the Regev and Weissman labs describing Perturb-seq, and its importance has only grown over time. They ingeniously fused pooled CRISPR-based genetic screens with high-throughput single-cell RNA-sequencing. This creates a system where, in a single experiment, you can knock out hundreds of different genes across a population of cells and read out the full transcriptional consequence of each specific perturbation inside each individual cell. It&amp;rsquo;s a landmark in functional genomics.&lt;/p&gt;
&lt;h2 id=&#34;breaking-the-screen-or-profile-dilemma&#34;&gt;Breaking the Screen-or-Profile Dilemma&lt;/h2&gt;
&lt;p&gt;The scientific quest here was to resolve a frustrating tradeoff that defined functional genomics for years. On one side, we had pooled CRISPR screens. These are incredibly scalable—you can test thousands of genes at once—but the readout is typically a single, low-content metric like cell survival or the expression of one fluorescent reporter. You learn &lt;em&gt;that&lt;/em&gt; a gene is important, but not &lt;em&gt;why&lt;/em&gt;. On the other side, we could perform RNA-seq on cells after knocking out a single gene. This gives an incredibly rich, high-content view of the molecular fallout, but it&amp;rsquo;s painstakingly slow and expensive, done one gene at a time. The central challenge was how to get the best of both: the massive scale of a pooled screen combined with the deep, mechanistic insight of whole-transcriptome profiling.&lt;/p&gt;
&lt;h2 id=&#34;the-barcode-is-the-rosetta-stone&#34;&gt;The Barcode is the Rosetta Stone&lt;/h2&gt;
&lt;p&gt;The core of Perturb-seq is an elegant technical and computational solution. The key is a lentiviral vector that delivers not only a specific single-guide RNA (sgRNA) to enact a CRISPR knockout but also a transcribed &amp;ldquo;guide barcode&amp;rdquo; (GBC). When the cells are processed using droplet-based scRNA-seq, this GBC is captured along with all the other mRNAs from that cell. The GBC is the Rosetta Stone: it allows the authors to definitively link a specific genetic perturbation to a specific high-dimensional transcriptomic profile for thousands of cells in parallel.&lt;/p&gt;
&lt;p&gt;Computationally, they then developed a framework (MIMOSCA) to make sense of this massive dataset. Using a regularized linear model, they can deconvolve the specific effect of each perturbation from the complex, pooled data. Crucially, the model is designed to parse out the true perturbation effects from other sources of variation, like the cell cycle, technical noise, or batch effects, which is essential for isolating a clean biological signal.&lt;/p&gt;
&lt;h2 id=&#34;from-single-genes-to-a-network-diagram&#34;&gt;From Single Genes to a Network Diagram&lt;/h2&gt;
&lt;p&gt;The finding that truly drives home the power of this method isn&amp;rsquo;t just the ability to see which genes go up or down after a knockout. The &amp;lsquo;aha!&amp;rsquo; moment is seeing how they use these rich phenotypes to reconstruct biological circuits. In their demonstration in bone marrow-derived dendritic cells (BMDCs), they perturbed 24 different transcription factors (TFs) involved in the immune response. By clustering the resulting transcriptional signatures, they could group TFs into functional modules—for example, correctly identifying Stat1 and Stat2 as a cooperative module in the anti-viral response. They went beyond a simple list of gene-phenotype links and generated a data-driven wiring diagram of the regulatory network, complete with activating and repressive relationships. This is a monumental step towards interpretability and systems-level understanding.&lt;/p&gt;
&lt;h2 id=&#34;this-isnt-just-a-paper-its-my-labs-foundation&#34;&gt;This Isn&amp;rsquo;t Just a Paper; It&amp;rsquo;s My Lab&amp;rsquo;s Foundation&lt;/h2&gt;
&lt;p&gt;I can&amp;rsquo;t overstate this: Perturb-seq is the bedrock of my research philosophy and the engine for my entire lab&amp;rsquo;s mission. My goal is to build predictive, causal models of tissues, and this technology is the single most effective tool for generating the necessary causal data at scale.&lt;/p&gt;
&lt;p&gt;I can use this exact framework to knock out hundreds of candidate genes in T-ALL cell lines, expose them to chemotherapy, and identify the complete transcriptional programs that are &lt;em&gt;causally&lt;/em&gt; responsible for driving chemoresistance. I can also screen for genes in cancer cells that causally alter the expression of checkpoint ligands or, in co-culture systems, screen for genes in T-cells that drive the exhaustion phenotype.&lt;/p&gt;
&lt;p&gt;This method is the physical embodiment of my guiding principles. It moves beyond correlation to &lt;strong&gt;causality&lt;/strong&gt; via direct perturbation. It enables &lt;strong&gt;prediction&lt;/strong&gt; by showing what happens to the entire cellular system &lt;em&gt;if&lt;/em&gt; a specific gene is removed. And the high-content transcriptomic readout provides the raw material needed to build &lt;strong&gt;interpretable&lt;/strong&gt; models of the underlying gene regulatory networks.&lt;/p&gt;
&lt;h2 id=&#34;scaling-causality-multi-omics-and-in-vivo-screens&#34;&gt;Scaling Causality: Multi-omics and In Vivo Screens&lt;/h2&gt;
&lt;p&gt;The original Perturb-seq paper was a starting pistol, not a finish line. It immediately opened doors to even more powerful applications, which is where I plan to focus my own computational efforts.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;My Next Computational Step:&lt;/strong&gt; The logical evolution is to move from a single RNA readout to a multi-modal one. My immediate focus is on building the analytical frameworks to handle Perturb-Multiome, where we simultaneously profile the transcriptome and the epigenome (via scATAC-seq) from each perturbed cell. This allows us to ask deeper causal questions: how does knocking out a transcription factor causally rewire the chromatin landscape, and how do those changes then propagate to the transcriptome? This gives us a much more mechanistic, multi-layered view of gene regulation.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Key Experiment for the Field:&lt;/strong&gt; The experiments in this paper were performed in cell culture. The ultimate challenge and next frontier is to take this technology &lt;em&gt;in vivo&lt;/em&gt;. The key experiment would be to transduce a population of tumor cells with a Perturb-seq library, implant them into an immunocompetent mouse model, and allow a tumor to form. Upon excision, performing scRNA-seq on the tumor would reveal which genetic knockouts causally impact a cell&amp;rsquo;s fitness, metastatic potential, and its interaction with the native immune system within the true complexity of the tumor microenvironment.&lt;/p&gt;
&lt;h2 id=&#34;reading-the-fine-print-limitations-and-lookouts&#34;&gt;Reading the Fine Print: Limitations and Lookouts&lt;/h2&gt;
&lt;p&gt;For all its power, the approach isn&amp;rsquo;t without its caveats. First, the model has to infer which cells actually had a successful gene knockout, as CRISPR is not 100% efficient. This introduces a potential source of noise, as the &amp;ldquo;unaffected&amp;rdquo; cells can dampen the measured average effect size for a given perturbation. Second, the biological context is critical. An effect observed in a cell line grown in a dish may not translate directly to a complex tissue &lt;em&gt;in vivo&lt;/em&gt;, where extrinsic signals from neighboring cells can buffer or modify the outcome of a perturbation. Finally, while the paper demonstrated simple pairwise interactions, the combinatorial space of genetic interactions is astronomically large. Systematically screening all pairs, triplets, and higher-order combinations remains a monumental challenge, forcing us to rely on assumptions of sparsity—that most factors don&amp;rsquo;t interact—which may not always be true.&lt;/p&gt;
&lt;hr&gt;
&lt;h3 id=&#34;reference&#34;&gt;Reference&lt;/h3&gt;
&lt;p&gt;Dixit, Atray, et al. &lt;a href=&#34;http://dx.doi.org/10.1016/j.cell.2016.11.038&#34;&gt;&amp;ldquo;Perturb-Seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens.&amp;quot;&lt;/a&gt; cell 167.7 (2016): 1853-1866.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
